Structure based design:: Novel spirocyclic ethers as nonpeptidal P2-ligands for HIV protease inhibitors

被引:33
作者
Ghosh, AK
Krishnan, K
Walters, DE
Cho, WH
Cho, H
Koo, Y
Trevino, J
Holland, L
Buthod, J
机构
[1] Univ Illinois, Dept Chem, Chicago, IL 60607 USA
[2] Finch Univ Hlth Sci Chicago Med Sch, Dept Biol Chem, N Chicago, IL 60064 USA
[3] IIT, Res Inst, Dept Life Sci, Chicago, IL 60616 USA
关键词
D O I
10.1016/S0960-894X(98)00139-5
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
A series of novel spirocyclic ethers were designed to function as nonpeptidal P-2-ligands for HIV-1 protease inhibitors. Incorporation of designed ligands in the (R)-(hydroxyethylamino)sulfonamide isostere afforded potent HIV protease inhibitors. (C) 1998 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:979 / 982
页数:4
相关论文
共 19 条
[1]   Evaluation of furofuran as a P-2 ligand for symmetry-based HIV protease inhibitors [J].
Chen, XQ ;
Li, L ;
Kempf, DJ ;
Sham, H ;
Wideburg, NE ;
Saldivar, A ;
Vasavanonda, S ;
Marsh, KC ;
McDonald, E ;
Norbeck, DW .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (23) :2847-2852
[2]   ANTIVIRAL PROPERTIES OF RO 31-8959, AN INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) PROTEINASE [J].
CRAIG, JC ;
DUNCAN, IB ;
HOCKLEY, D ;
GRIEF, C ;
ROBERTS, NA ;
MILLS, JS .
ANTIVIRAL RESEARCH, 1991, 16 (04) :295-305
[3]   CRAM RULE SELECTIVITY IN THE LEWIS ACID-CATALYZED CYCLOCONDENSATION OF CHIRAL ALDEHYDES - A CONVENIENT ROUTE TO CHIRAL SYSTEMS OF BIOLOGICAL INTEREST [J].
DANISHEFSKY, S ;
KOBAYASHI, S ;
KERWIN, JF .
JOURNAL OF ORGANIC CHEMISTRY, 1982, 47 (10) :1981-1983
[4]   THE HIV-1 PROTEASE AS A THERAPEUTIC TARGET FOR AIDS [J].
DEBOUCK, C .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1992, 8 (02) :153-164
[5]   STRUCTURE-BASED DESIGN OF HIV-1 PROTEASE INHIBITORS - REPLACEMENT OF 2 AMIDES AND A 10-PI-AROMATIC SYSTEM BY A FUSED BIS-TETRAHYDROFURAN [J].
GHOSH, AK ;
THOMPSON, WJ ;
FITZGERALD, PMD ;
CULBERSON, JC ;
AXEL, MG ;
MCKEE, SP ;
HUFF, JR ;
ANDERSON, PS .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (16) :2506-2508
[6]   THE DEVELOPMENT OF CYCLIC SULFOLANES AS NOVEL AND HIGH-AFFINITY P(2) LIGANDS FOR HIV-1 PROTEASE INHIBITORS [J].
GHOSH, AK ;
LEE, HY ;
THOMPSON, WJ ;
CULBERSON, C ;
HOLLOWAY, MK ;
MCKEE, SP ;
MUNSON, PM ;
DUONG, TT ;
SMITH, AM ;
DARKE, PL ;
ZUGAY, JA ;
EMINI, EA ;
SCHLEIF, WA ;
HUFF, JR ;
ANDERSON, PS .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (08) :1177-1188
[7]   POTENT HIV PROTEASE INHIBITORS - THE DEVELOPMENT OF TETRAHYDROFURANYLGLYCINES AS NOVEL P(2)-LIGANDS AND PYRAZINE AMIDES AS P(3)-LIGANDS [J].
GHOSH, AK ;
THOMPSON, WJ ;
HOLLOWAY, MK ;
MCKEE, SP ;
DUONG, TT ;
LEE, HY ;
MUNSON, PM ;
SMITH, AM ;
WAI, JM ;
DARKE, PL ;
ZUGAY, JA ;
EMINI, EA ;
SCHLEIF, WA ;
HUFF, JR ;
ANDERSON, PS .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (16) :2300-2310
[8]   Nonpeptidal P-2 ligands for HIV protease inhibitors: Structure-based design, synthesis, and biological evaluation [J].
Ghosh, AK ;
Kincaid, JF ;
Walters, DE ;
Chen, Y ;
Chaudhuri, NC ;
Thompson, WJ ;
Culberson, C ;
Fitzgerald, PMD ;
Lee, HY ;
McKee, SP ;
Munson, PM ;
Duong, TT ;
Darke, PL ;
Zugay, JA ;
Schleif, WA ;
Axel, MG ;
Lin, J ;
Huff, JR .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (17) :3278-3290
[9]   CYCLIC SULFONE-3-CARBOXAMIDES AS NOVEL P-2-LIGANDS FOR RO-31-8959 BASED HIV-1 PROTEASE INHIBITORS [J].
GHOSH, AK ;
THOMPSON, WJ ;
MUNSON, PM ;
LIU, WM ;
HUFF, JR .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (01) :83-88
[10]   CYCLIC SULFOLANES AS NOVEL AND HIGH-AFFINITY P-2 LIGANDS FOR HIV-1 PROTEASE INHIBITORS [J].
GHOSH, AK ;
THOMPSON, WJ ;
LEE, HY ;
MCKEE, SP ;
MUNSON, PM ;
DUONG, TT ;
DARKE, PL ;
ZUGAY, JA ;
EMINI, EA ;
SCHLEIF, WA ;
HUFF, JR ;
ANDERSON, PS .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (07) :924-927